Malignant teratoma of mediastinum

Summary

Malignant teratoma of mediastinum (MONDO:0021283) is a disease. A subtype of malignant teratoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	malignant teratoma of mediastinum
Mondo ID	MONDO:0021283
NCIT	C4668
SNOMED CT	278042005
UMLS	C0349663
MedGen	91164
GARD	0025306
Anatomy (UBERON)	UBERON:0003728
Is cancer (heuristic)	no

Also known as: immature malignant teratoma of mediastinum · immature malignant teratoma of the mediastinum · malignant mediastinal teratoma · malignant teratoma of the mediastinum · mediastinal immature malignant teratoma · mediastinum malignant teratoma

Disease family

This is a subtype of malignant teratoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › germ cell tumor › nongerminomatous germ cell tumor › teratoma › malignant teratoma › malignant teratoma of mediastinum

Related subtypes (6): pineal region immature teratoma, immature gastric teratoma, intermediate malignant teratoma, immature ovarian teratoma, malignant teratoma of testis, immature extragonadal teratoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.